Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP49 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP37 USP20 USP17L18 USP44 USP26 USP14 USP6 USP8 USP38 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP33 USP17L8 USP17L13	4.62e-43	114	110	30	GO:0004843
GeneOntologyMolecularFunction	deubiquitinase activity	USP49 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP37 USP20 USP17L18 USP44 USP26 USP14 USP6 USP8 USP38 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP33 USP17L8 USP17L13	8.02e-42	124	110	30	GO:0101005
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP49 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP37 USP20 USP17L18 USP44 USP26 USP14 USP6 USP8 USP38 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP33 USP17L8 USP17L13	2.25e-40	137	110	30	GO:0019783
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP49 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 CASP1 USP17L5 USP17L10 USP17L19 USP37 USP20 USP17L18 USP44 USP26 USP14 USP6 USP8 USP38 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP33 USP17L8 USP17L13	2.72e-37	192	110	31	GO:0008234
GeneOntologyMolecularFunction	peptidase activity	USP49 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 CASP1 USP17L5 USP17L10 USP17L19 USP37 USP20 USP17L18 USP44 USP26 USP14 USP6 USP8 USP38 USP17L17 USP17L6P USP17L3 MME USP17L22 USP17L15 USP33 USP17L8 USP17L13	7.06e-22	654	110	32	GO:0008233
GeneOntologyMolecularFunction	cysteine-type endopeptidase activity	USP49 CASP1 USP37 USP20 USP14 USP6 USP8 USP33	2.44e-08	86	110	8	GO:0004197
GeneOntologyMolecularFunction	cell-cell adhesion mediator activity	DSCAM DSP CNTN5 PKP2 CNTN2	2.15e-05	61	110	5	GO:0098632
GeneOntologyMolecularFunction	interleukin-33 receptor activity	IL1RL1 IL1RAP	3.01e-05	2	110	2	GO:0002114
GeneOntologyMolecularFunction	carbohydrate binding	MRC1 ENPP1 REG1A REG1B IGF2R FCN1 LY75 ADGRL2 CNTN2	5.49e-05	310	110	9	GO:0030246
GeneOntologyMolecularFunction	cell adhesion mediator activity	DSCAM DSP CNTN5 PKP2 CNTN2	6.27e-05	76	110	5	GO:0098631
GeneOntologyMolecularFunction	cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication	DSP PKP2	2.97e-04	5	110	2	GO:0086083
GeneOntologyMolecularFunction	endopeptidase activity	USP49 CASP1 USP37 USP20 USP14 USP6 USP8 MME USP33	6.25e-04	430	110	9	GO:0004175
GeneOntologyMolecularFunction	interleukin-1 receptor activity	IL1RL1 IL1RAP	8.24e-04	8	110	2	GO:0004908
GeneOntologyBiologicalProcess	protein deubiquitination	USP49 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP37 USP20 USP17L18 USP44 USP26 USP14 USP6 USP8 USP38 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP33 USP17L8 USP17L13	1.27e-40	125	107	29	GO:0016579
GeneOntologyBiologicalProcess	protein modification by small protein removal	USP49 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP37 USP20 USP17L18 USP44 USP26 USP14 USP6 USP8 USP38 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP33 USP17L8 USP17L13	1.18e-38	144	107	29	GO:0070646
GeneOntologyBiologicalProcess	post-translational protein modification	USP49 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 ENPP1 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP37 USP20 MAP3K1 USP17L18 USP44 USP26 USP14 USP6 USP8 USP38 USP17L17 TRIM32 USP17L6P USP17L3 USP17L22 USP17L15 USP33 USP17L8 PARP12 USP17L13	2.86e-17	1074	107	33	GO:0043687
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	USP49 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP37 USP20 MAP3K1 USP17L18 USP44 USP26 USP14 USP6 USP8 USP38 USP17L17 TRIM32 USP17L6P USP17L3 USP17L22 USP17L15 USP33 USP17L8 USP17L13	3.35e-16	1009	107	31	GO:0070647
GeneOntologyBiologicalProcess	protein K48-linked deubiquitination	USP17L2 USP37 USP20 USP8 USP33	5.22e-07	31	107	5	GO:0071108
GeneOntologyBiologicalProcess	protein K63-linked deubiquitination	USP17L2 USP20 USP8 USP33	2.20e-05	32	107	4	GO:0070536
GeneOntologyBiologicalProcess	pancreas regeneration	REG1A REG1B	2.67e-05	2	107	2	GO:1990798
GeneOntologyBiologicalProcess	regulation of ventricular cardiac muscle cell action potential	CACNA1C DSP PKP2	2.89e-05	12	107	3	GO:0098911
GeneOntologyBiologicalProcess	defense response to symbiont	MRC1 RIPK3 USP17L2 HLA-F CASP1 CEACAM6 ABCC9 REG1A REG1B BCL3 USP20 USP44 USP14 RNASE1 RNASE6 USP38 TRIM32 FCN1 IL1RAP	3.14e-05	1286	107	19	GO:0140546
GeneOntologyBiologicalProcess	defense response to other organism	MRC1 RIPK3 USP17L2 ENPP1 HLA-F CASP1 CEACAM6 ABCC9 REG1A REG1B BCL3 USP20 USP44 USP14 RNASE1 RNASE6 USP38 TRIM32 FCN1 IL1RAP	3.26e-05	1407	107	20	GO:0098542
GeneOntologyBiologicalProcess	defense response to virus	RIPK3 USP17L2 CASP1 ABCC9 USP20 USP44 RNASE1 RNASE6 TRIM32	7.35e-05	342	107	9	GO:0051607
GeneOntologyBiologicalProcess	response to virus	RIPK3 USP17L2 CASP1 ABCC9 BCL3 USP20 USP44 RNASE1 RNASE6 TRIM32	7.36e-05	425	107	10	GO:0009615
GeneOntologyBiologicalProcess	positive regulation of acinar cell proliferation	REG1A REG1B	7.97e-05	3	107	2	GO:1904699
GeneOntologyBiologicalProcess	neuron projection development	ARHGAP32 DSCAM WEE1 ENPP1 HLA-F REG1A REG1B ITGA3 TECTA CSMD3 ASAP1 HOXA2 LRIG2 NRXN3 TRIM32 CNTN5 CNTN2 USP33	1.03e-04	1285	107	18	GO:0031175
GeneOntologyBiologicalProcess	dendrite self-avoidance	DSCAM CNTN5 CNTN2	1.05e-04	18	107	3	GO:0070593
GeneOntologyBiologicalProcess	regulation of acinar cell proliferation	REG1A REG1B	2.64e-04	5	107	2	GO:1904697
GeneOntologyBiologicalProcess	actin modification	TRIM32 SETD3	2.64e-04	5	107	2	GO:0030047
GeneOntologyBiologicalProcess	acinar cell proliferation	REG1A REG1B	2.64e-04	5	107	2	GO:1990863
GeneOntologyCellularComponent	endoplasmic reticulum membrane	USP17L21 ARHGAP32 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 CALHM1 USP17L11 HLA-F USP17L5 SLC26A9 USP17L10 USP17L19 SEC22A USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.77e-07	1293	109	23	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	USP17L21 ARHGAP32 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 CALHM1 USP17L11 HLA-F USP17L5 SLC26A9 USP17L10 USP17L19 SEC22A USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.93e-07	1299	109	23	GO:0098827
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	USP17L21 ARHGAP32 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 CALHM1 USP17L11 HLA-F USP17L5 SLC26A9 USP17L10 USP17L19 SEC22A USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.81e-07	1327	109	23	GO:0042175
MousePheno	increased trophectoderm apoptosis	USP17L2 USP17L15 USP17L13	8.82e-06	8	77	3	MP:0012119
Domain	UCH	USP49 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP37 USP20 USP17L18 USP44 USP26 USP14 USP6 USP8 USP38 USP17L17 USP17L3 USP17L22 USP33 USP17L8 USP17L13	6.25e-44	71	103	27	PF00443
Domain	USP_2	USP49 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP37 USP20 USP17L18 USP44 USP26 USP14 USP6 USP8 USP38 USP17L17 USP17L3 USP17L22 USP33 USP17L8 USP17L13	6.25e-44	71	103	27	PS00973
Domain	USP_3	USP49 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP37 USP20 USP17L18 USP44 USP26 USP14 USP6 USP8 USP38 USP17L17 USP17L3 USP17L22 USP33 USP17L8 USP17L13	9.96e-44	72	103	27	PS50235
Domain	USP_dom	USP49 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP37 USP20 USP17L18 USP44 USP26 USP14 USP6 USP8 USP38 USP17L17 USP17L3 USP17L22 USP33 USP17L8 USP17L13	9.96e-44	72	103	27	IPR028889
Domain	Peptidase_C19_UCH	USP49 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP37 USP20 USP17L18 USP44 USP26 USP14 USP6 USP8 USP38 USP17L17 USP17L3 USP17L22 USP33 USP17L8 USP17L13	9.96e-44	72	103	27	IPR001394
Domain	USP_CS	USP49 USP17L21 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP37 USP20 USP17L18 USP44 USP26 USP14 USP6 USP8 USP38 USP17L17 USP17L3 USP17L22 USP33 USP17L8 USP17L13	8.65e-43	66	103	26	IPR018200
Domain	USP_1	USP49 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP37 USP20 USP17L18 USP44 USP26 USP14 USP6 USP8 USP38 USP17L17 USP17L3 USP17L22 USP33 USP17L8 USP17L13	5.75e-42	70	103	26	PS00972
Domain	HABP4_PAI-RBP1	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	1.10e-27	16	103	13	PF04774
Domain	HABP4_PAIRBP1-bd	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	1.10e-27	16	103	13	IPR006861
Domain	ZnF_UBP	USP49 USP20 USP44 USP33	2.79e-07	11	103	4	SM00290
Domain	Znf_UBP	USP49 USP20 USP44 USP33	8.37e-07	14	103	4	IPR001607
Domain	zf-UBP	USP49 USP20 USP44 USP33	8.37e-07	14	103	4	PF02148
Domain	ZF_UBP	USP49 USP20 USP44 USP33	8.37e-07	14	103	4	PS50271
Domain	Ig_I-set	MXRA5 DSCAM CEACAM6 LINGO2 LRIG2 CNTN5 IL1RL1 CNTN2	1.03e-05	190	103	8	IPR013098
Domain	I-set	MXRA5 DSCAM CEACAM6 LINGO2 LRIG2 CNTN5 IL1RL1 CNTN2	1.03e-05	190	103	8	PF07679
Domain	IGc2	MXRA5 DSCAM CEACAM6 LINGO2 LRIG2 CNTN5 IL1RL1 CNTN2	4.75e-05	235	103	8	SM00408
Domain	Ig_sub2	MXRA5 DSCAM CEACAM6 LINGO2 LRIG2 CNTN5 IL1RL1 CNTN2	4.75e-05	235	103	8	IPR003598
Domain	FN_type2_col-bd	MRC1 IGF2R LY75	5.67e-05	14	103	3	IPR000562
Domain	FN2_2	MRC1 IGF2R LY75	5.67e-05	14	103	3	PS51092
Domain	fn2	MRC1 IGF2R LY75	5.67e-05	14	103	3	PF00040
Domain	FN2_1	MRC1 IGF2R LY75	5.67e-05	14	103	3	PS00023
Domain	FN2	MRC1 IGF2R LY75	5.67e-05	14	103	3	SM00059
Domain	USP37-like_PH	USP37 USP26	9.00e-05	3	103	2	IPR032069
Domain	UCH_N	USP37 USP26	9.00e-05	3	103	2	PF16674
Domain	C-type_lectin_CS	MRC1 REG1A REG1B LY75	9.12e-05	43	103	4	IPR018378
Domain	IG_LIKE	MXRA5 DSCAM HLA-F CEACAM6 LINGO2 LRIG2 CNTN5 IL1RL1 IL1RAP CNTN2	3.82e-04	491	103	10	PS50835
Domain	DUSP	USP20 USP33	4.45e-04	6	103	2	SM00695
Domain	IL-1_rcpt_I/II-typ	IL1RL1 IL1RAP	4.45e-04	6	103	2	IPR004074
Domain	DUSP	USP20 USP33	4.45e-04	6	103	2	PF06337
Domain	Ig-like_dom	MXRA5 DSCAM HLA-F CEACAM6 LINGO2 LRIG2 CNTN5 IL1RL1 IL1RAP CNTN2	4.61e-04	503	103	10	IPR007110
Domain	IG	MXRA5 DSCAM CEACAM6 LINGO2 LRIG2 CNTN5 IL1RL1 IL1RAP CNTN2	5.34e-04	421	103	9	SM00409
Domain	Ig_sub	MXRA5 DSCAM CEACAM6 LINGO2 LRIG2 CNTN5 IL1RL1 IL1RAP CNTN2	5.34e-04	421	103	9	IPR003599
Domain	-	USP20 USP33	6.21e-04	7	103	2	3.30.2230.10
Domain	DUSP	USP20 USP33	6.21e-04	7	103	2	PS51283
Domain	Pept_C19_DUSP	USP20 USP33	6.21e-04	7	103	2	IPR006615
Domain	Kringle-like	MRC1 IGF2R LY75	7.19e-04	32	103	3	IPR013806
Domain	RNaseA_AS	RNASE1 RNASE6	8.25e-04	8	103	2	IPR023411
Domain	RNASE_PANCREATIC	RNASE1 RNASE6	8.25e-04	8	103	2	PS00127
Domain	C_TYPE_LECTIN_1	MRC1 REG1A REG1B LY75	1.00e-03	80	103	4	PS00615
Domain	Lectin_C	MRC1 REG1A REG1B LY75	1.20e-03	84	103	4	PF00059
Domain	CLECT	MRC1 REG1A REG1B LY75	1.20e-03	84	103	4	SM00034
Domain	C_TYPE_LECTIN_2	MRC1 REG1A REG1B LY75	1.25e-03	85	103	4	PS50041
Domain	C-type_lectin-like	MRC1 REG1A REG1B LY75	1.31e-03	86	103	4	IPR001304
Domain	NHL	LRP1B TRIM32	1.32e-03	10	103	2	PF01436
Domain	NHL_repeat	LRP1B TRIM32	1.32e-03	10	103	2	IPR001258
Domain	IL-1_rcpt_fam	IL1RL1 IL1RAP	1.60e-03	11	103	2	IPR015621
Domain	RNAse_Pc	RNASE1 RNASE6	1.60e-03	11	103	2	SM00092
Domain	DUF4599	SPATA31D4 SPATA31D3	1.92e-03	12	103	2	PF15371
Domain	DUF4599	SPATA31D4 SPATA31D3	1.92e-03	12	103	2	IPR027970
Domain	C-type_lectin-like/link	MRC1 REG1A REG1B LY75	2.20e-03	99	103	4	IPR016186
Domain	RNaseA	RNASE1 RNASE6	2.26e-03	13	103	2	PD000535
Domain	-	MRC1 IGF2R	2.26e-03	13	103	2	2.10.10.10
Domain	CTDL_fold	MRC1 REG1A REG1B LY75	2.91e-03	107	103	4	IPR016187
Domain	RNaseA	RNASE1 RNASE6	3.02e-03	15	103	2	IPR001427
Domain	RNaseA_domain	RNASE1 RNASE6	3.02e-03	15	103	2	IPR023412
Domain	RnaseA	RNASE1 RNASE6	3.02e-03	15	103	2	PF00074
Domain	-	RNASE1 RNASE6	3.02e-03	15	103	2	3.10.130.10
Domain	-	MXRA5 DSCAM HLA-F CEACAM6 LINGO2 LRIG2 CNTN5 IL1RL1 IL1RAP CNTN2	3.61e-03	663	103	10	2.60.40.10
Domain	ig	DSCAM CEACAM6 LRIG2 CNTN5 CNTN2	4.05e-03	190	103	5	PF00047
Domain	Immunoglobulin	DSCAM CEACAM6 LRIG2 CNTN5 CNTN2	4.05e-03	190	103	5	IPR013151
Pathway	REACTOME_RAS_PROCESSING	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	7.64e-29	45	90	18	MM15671
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP37 USP20 USP17L18 USP44 USP26 USP14 USP8 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP33 USP17L8 USP17L13	2.17e-26	191	90	25	MM15289
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP49 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP37 USP20 USP17L18 USP44 USP26 USP14 USP8 USP17L17 USP17L3 USP17L22 USP17L15 USP33 USP17L8 USP17L13	3.24e-26	221	90	26	M27578
Pathway	REACTOME_DEUBIQUITINATION	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP37 USP20 USP17L18 USP44 USP26 USP14 USP8 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP33 USP17L8 USP17L13	6.74e-23	262	90	25	MM15286
Pathway	REACTOME_DEUBIQUITINATION	USP49 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP37 USP20 USP17L18 USP44 USP26 USP14 USP8 USP17L17 USP17L3 USP17L22 USP17L15 USP33 USP17L8 USP17L13	8.96e-23	299	90	26	M27574
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.24e-12	318	90	18	MM15278
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 CEACAM6 USP17L5 USP17L10 USP17L19 TECTA USP37 SEC22A USP20 USP17L18 USP44 USP26 USP14 USP8 USP17L17 CNTN5 USP17L6P USP17L3 USP17L22 USP17L15 USP33 USP17L8 USP17L13	4.21e-09	1389	90	29	MM15307
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP49 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 TECTA USP37 SEC22A USP20 USP17L18 USP44 USP26 USP14 USP8 USP17L17 CNTN5 USP17L3 USP17L22 USP17L15 USP33 USP17L8 USP17L13	1.65e-08	1475	90	29	M19806
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.05e-43	21	110	18	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.05e-43	21	110	18	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.05e-43	21	110	18	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.05e-43	21	110	18	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.05e-43	21	110	18	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.05e-43	21	110	18	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.68e-42	22	110	18	9154835
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.07e-41	24	110	18	8995226
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.09e-40	25	110	18	21115691
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.54e-40	26	110	18	35816173
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.84e-40	33	110	19	20228807
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.09e-39	34	110	19	20403174
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.09e-39	34	110	19	14699124
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.09e-39	34	110	19	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.09e-39	34	110	19	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.09e-39	34	110	19	11941478
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.09e-39	34	110	19	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.09e-39	34	110	19	20388806
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.09e-39	34	110	19	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.09e-39	34	110	19	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.09e-39	34	110	19	20368735
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.09e-39	34	110	19	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.09e-39	34	110	19	21448158
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.39e-39	35	110	19	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.39e-39	35	110	19	21239494
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.05e-39	36	110	19	20147298
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	7.79e-39	29	110	18	32527007
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.03e-38	37	110	19	20228808
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 KLF18 USP17L22 USP17L15 USP17L8 USP17L13	1.72e-35	50	110	19	31806660
Pubmed	Human and mouse proteases: a comparative genomic approach.	USP17L4 USP17L2 USP17L1 USP37 USP20 USP44 USP26 USP14 USP6 USP8 USP38 USP17L6P USP17L3 USP17L15 USP33 USP17L8	9.10e-25	81	110	16	12838346
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	CACNA1C MRC1 USP17L21 MAGEA11 SCHIP1 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 HLA-F CEACAM6 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 LY75 USP17L22 USP17L15 USP17L8 USP17L13	7.64e-20	674	110	25	37196079
Pubmed	High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.	USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	3.10e-16	10	110	7	24207026
Pubmed	Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells.	USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	2.04e-15	12	110	7	24695638
Pubmed	ES cell neural differentiation reveals a substantial number of novel ESTs.	USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	8.79e-15	14	110	7	11793228
Pubmed	CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1.	USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	1.27e-13	19	110	7	28067227
Pubmed	OTUD6A Is an Aurora Kinase A-Specific Deubiquitinase.	USP17L2 USP37 USP20 USP44 USP6 USP33	7.39e-10	32	110	6	33669244
Pubmed	Ubiquitin-specific peptidase 2a (USP2a) deubiquitinates and stabilizes β-catenin.	USP49 USP17L2 USP37 USP20 USP33	6.39e-08	33	110	5	30323974
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L19 USP17L18 USP17L17	1.09e-07	119	110	7	28625976
Pubmed	Embryonic demise caused by targeted disruption of a cysteine protease Dub-2.	USP17L2 USP17L15 USP17L13	1.23e-07	4	110	3	22984479
Pubmed	DNA sequence and analysis of human chromosome 8.	USP17L4 USP17L1 ASAP1 USP17L3 USP17L8	4.44e-07	48	110	5	16421571
Pubmed	Discovery and Characterization of ZUFSP/ZUP1, a Distinct Deubiquitinase Class Important for Genome Stability.	USP37 USP20 USP14 USP6 USP8 USP38 USP33	4.62e-07	147	110	7	29576527
Pubmed	Modulation of fatty acid synthase degradation by concerted action of p38 MAP kinase, E3 ligase COP1, and SH2-tyrosine phosphatase Shp2.	REG1A REG1B FASN	6.11e-07	6	110	3	23269672
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	USP49 USP17L2 USP37 USP20 USP44 USP26 USP14 USP6 USP8 IGF2R USP38 RPTN USP33 PHLPP2 BORA	6.72e-07	1005	110	15	19615732
Pubmed	Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases.	USP49 USP37 USP44 USP38	8.01e-07	23	110	4	14715245
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	DSCAM CEACAM6 LINGO2 LRIG2 CNTN5 IL1RAP CNTN2	8.89e-07	162	110	7	25826454
Pubmed	Self-stabilizing regulation of deubiquitinating enzymes in an enzymatic activity-dependent manner.	USP37 USP26 USP38	1.70e-06	8	110	3	33864866
Pubmed	Mitochondrial apoptosis is dispensable for NLRP3 inflammasome activation but non-apoptotic caspase-8 is required for inflammasome priming.	RIPK3 CASP1 PPIF	2.55e-06	9	110	3	24990442
Pubmed	A microarray of ubiquitylated proteins for profiling deubiquitylase activity reveals the critical roles of both chain and substrate.	USP20 USP14 USP8 USP33	5.16e-06	36	110	4	22626734
Pubmed	Lysine demethylase 7a regulates murine anterior-posterior development by modulating the transcription of Hox gene cluster.	HOXA2 HOXC5 HOXD13 KDM7A	7.15e-06	39	110	4	33257809
Pubmed	Prognostic role of regenerating gene-I in patients with stage-IV head and neck squamous cell carcinoma.	REG1A REG1B	9.91e-06	2	110	2	27539087
Pubmed	Helicobacter and gastrin stimulate Reg1 expression in gastric epithelial cells through distinct promoter elements.	REG1A REG1B	9.91e-06	2	110	2	17463184
Pubmed	The expression of REG 1A and REG 1B is increased during acute amebic colitis.	REG1A REG1B	9.91e-06	2	110	2	21586335
Pubmed	Characterization of CaV1.2 exon 33 heterozygous knockout mice and negative correlation between Rbfox1 and CaV1.2 exon 33 expressions in human heart failure.	CACNA1C RBFOX1	9.91e-06	2	110	2	28949795
Pubmed	Cleavage of the Arg-Ile bond in the native polypeptide chain of human pancreatic stone protein.	REG1A REG1B	9.91e-06	2	110	2	3108036
Pubmed	The human reg gene encodes pancreatic stone protein.	REG1A REG1B	9.91e-06	2	110	2	2764894
Pubmed	Pancreatic acinar-specific overexpression of Reg2 gene offered no protection against either experimental diabetes or pancreatitis in mice.	REG1A REG1B	9.91e-06	2	110	2	20489047
Pubmed	Pancreatic regenerating gene overexpression in the nonobese diabetic mouse during active diabetogenesis.	REG1A REG1B	9.91e-06	2	110	2	8522062
Pubmed	Caspase-1 inhibition improves cognition without significantly altering amyloid and inflammation in aged Alzheimer disease mice.	ZBTB20 CASP1	9.91e-06	2	110	2	36220815
Pubmed	Production and characterization of Reg knockout mice: reduced proliferation of pancreatic beta-cells in Reg knockout mice.	REG1A REG1B	9.91e-06	2	110	2	12475793
Pubmed	Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury.	RIPK3 PPIF	9.91e-06	2	110	2	23818611
Pubmed	Ubiquitin specific peptidase 38 promotes the progression of gastric cancer through upregulation of fatty acid synthase.	FASN USP38	9.91e-06	2	110	2	35812059
Pubmed	Associations of IL1RAP and IL1RL1 gene polymorphisms with obesity and inflammation mediators.	IL1RL1 IL1RAP	9.91e-06	2	110	2	31897507
Pubmed	Cellular mechanisms underlying failed beta cell regeneration in offspring of protein-restricted pregnant mice.	REG1A REG1B	9.91e-06	2	110	2	23986224
Pubmed	Reg-II is an exocrine pancreas injury-response product that is up-regulated by keratin absence or mutation.	REG1A REG1B	9.91e-06	2	110	2	17898082
Pubmed	Expression of Reg family genes in the gastrointestinal tract of mice treated with indomethacin.	REG1A REG1B	9.91e-06	2	110	2	25747353
Pubmed	Complete amino acid sequence of an immunoreactive form of human pancreatic stone protein isolated from pancreatic juice.	REG1A REG1B	9.91e-06	2	110	2	3665916
Pubmed	Neuronal neprilysin overexpression is associated with attenuation of Abeta-related spatial memory deficit.	ZBTB20 MME	9.91e-06	2	110	2	17008108
Pubmed	RegII is a beta-cell protein and autoantigen in diabetes of NOD mice.	REG1A REG1B	9.91e-06	2	110	2	17192462
Pubmed	Crystal structure of human lithostathine, the pancreatic inhibitor of stone formation.	REG1A REG1B	9.91e-06	2	110	2	8654365
Pubmed	No abnormalities of reg1 alpha and reg1 beta gene associated with diabetes mellitus.	REG1A REG1B	9.91e-06	2	110	2	11796176
Pubmed	Protein-X, Pancreatic Stone-, Pancreatic thread-, reg-protein, P19, lithostathine, and now what? Characterization, structural analysis and putative function(s) of the major non-enzymatic protein of pancreatic secretions.	REG1A REG1B	9.91e-06	2	110	2	12369899
Pubmed	A novel gene activated in regenerating islets.	REG1A REG1B	9.91e-06	2	110	2	2963000
Pubmed	Deubiquitinases USP20/33 promote the biogenesis of tail-anchored membrane proteins.	USP20 USP33	9.91e-06	2	110	2	33792613
Pubmed	Structure, chromosomal localization, and expression of mouse reg genes, reg I and reg II. A novel type of reg gene, reg II, exists in the mouse genome.	REG1A REG1B	9.91e-06	2	110	2	8340418
Pubmed	Necroptosis Interfaces with MOMP and the MPTP in Mediating Cell Death.	RIPK3 PPIF	9.91e-06	2	110	2	26061004
Pubmed	Regenerating 1 and 3b gene expression in the pancreas of type 2 diabetic Goto-Kakizaki (GK) rats.	REG1A REG1B	9.91e-06	2	110	2	24587207
Pubmed	Partial amino acid sequence of human pancreatic stone protein, a novel pancreatic secretory protein.	REG1A REG1B	9.91e-06	2	110	2	3541906
Pubmed	USP14 Regulates Cancer Cell Growth in a Fatty Acid Synthase-Independent Manner.	USP14 FASN	9.91e-06	2	110	2	34948233
Pubmed	Differential expression of reg-I and reg-II genes during aging in the normal mouse.	REG1A REG1B	9.91e-06	2	110	2	8808978
Pubmed	Preferential expression of reg I beta gene in human adult pancreas.	REG1A REG1B	9.91e-06	2	110	2	11396963
Pubmed	RIP3 deficiency ameliorates inflammatory response in mice infected with influenza H7N9 virus infection.	RIPK3 CASP1	9.91e-06	2	110	2	28423682
Pubmed	The Role of SNPs in IL1RL1 and IL1RAP Genes in Age-related Macular Degeneration Development and Treatment Efficacy.	IL1RL1 IL1RAP	9.91e-06	2	110	2	32871771
Pubmed	Synergistic activations of REG I α and REG I β promoters by IL-6 and Glucocorticoids through JAK/STAT pathway in human pancreatic β cells.	REG1A REG1B	9.91e-06	2	110	2	25767811
Pubmed	Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.	ZBTB20 MME	9.91e-06	2	110	2	19228952
Pubmed	Isolation, structural determination and expression of a novel reg gene, human regI beta.	REG1A REG1B	9.91e-06	2	110	2	8110835
Pubmed	In vivo evidence for the role of RegI in gastric regeneration: transgenic overexpression of RegI accelerates the healing of experimental gastric ulcers.	REG1A REG1B	9.91e-06	2	110	2	20157293
Pubmed	Epicardial Ventricular Tachycardia Ablation in a Patient With Brugada ECG Pattern and Mutation of PKP2 and DSP Genes.	DSP PKP2	9.91e-06	2	110	2	25900994
Pubmed	Reg2 inactivation increases sensitivity to Fas hepatotoxicity and delays liver regeneration post-hepatectomy in mice.	REG1A REG1B	9.91e-06	2	110	2	17133485
Pubmed	Reg2 protects mouse insulinoma cells from streptozotocin-induced mitochondrial disruption and apoptosis.	REG1A REG1B	9.91e-06	2	110	2	20919961
Pubmed	Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse model.	ZBTB20 PPIF	9.91e-06	2	110	2	19362755
Pubmed	Reg I protein in healthy and seminoma human testis.	REG1A REG1B	9.91e-06	2	110	2	18712671
Pubmed	Diabetes and tumor formation in transgenic mice expressing Reg I.	REG1A REG1B	9.91e-06	2	110	2	11097844
Pubmed	mReg2 inhibits nuclear entry of apoptosis-inducing factor in mouse insulinoma cells.	REG1A REG1B	9.91e-06	2	110	2	25370781
Pubmed	N-terminal sequence extension in the glycosylated forms of human pancreatic stone protein. The 5-oxoproline N-terminal chain is O-glycosylated on the 5th amino acid residue.	REG1A REG1B	9.91e-06	2	110	2	2493268
Pubmed	Isolation and characterization of human reg protein produced in Saccharomyces cerevisiae.	REG1A REG1B	9.91e-06	2	110	2	2226837
Pubmed	Mechanism of calcite crystal growth inhibition by the N-terminal undecapeptide of lithostathine.	REG1A REG1B	9.91e-06	2	110	2	10625646
Pubmed	Reg2 Expression Is Required for Pancreatic Islet Compensation in Response to Aging and High-Fat Diet-Induced Obesity.	REG1A REG1B	9.91e-06	2	110	2	28009527
Pubmed	Exacerbation of indomethacin-induced small intestinal injuries in Reg I-knockout mice.	REG1A REG1B	9.91e-06	2	110	2	20508157
Pubmed	What function for human lithostathine?: structural investigations by three-dimensional structure modeling and high-resolution NMR spectroscopy.	REG1A REG1B	9.91e-06	2	110	2	8961348
Pubmed	Complete nucleotide sequence of human reg gene and its expression in normal and tumoral tissues. The reg protein, pancreatic stone protein, and pancreatic thread protein are one and the same product of the gene.	REG1A REG1B	9.91e-06	2	110	2	2332435
Interaction	IL1B interactions	RIPK3 CASP1 RBFOX1 IL1RL1 IL1RAP	1.38e-05	60	103	5	int:IL1B
Interaction	IL33 interactions	USP17L2 CASP1 IL1RL1	2.08e-05	11	103	3	int:IL33
Cytoband	4p16.1	USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	8.65e-25	79	110	15	4p16.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4p16	USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	8.98e-18	222	110	15	chr4p16
Cytoband	8p23.1	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	3.67e-05	154	110	5	8p23.1
Cytoband	Ensembl 112 genes in cytogenetic band chr8p23	USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	2.61e-04	234	110	5	chr8p23
Cytoband	9q21.32	SPATA31D4 SPATA31D3	9.47e-04	19	110	2	9q21.32
GeneFamily	Ubiquitin specific peptidases	USP49 USP17L2 USP37 USP20 USP44 USP26 USP14 USP6 USP8 USP38 USP33	1.67e-16	56	70	11	366
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	MXRA5 DSCAM LINGO2 LRIG2 CNTN5 IL1RL1 CNTN2	2.92e-06	161	70	7	593
GeneFamily	Immunoglobulin like domain containing	MXRA5 DSCAM CEACAM6 CNTN5 IL1RL1 IL1RAP CNTN2	9.62e-06	193	70	7	594
GeneFamily	HOXL subclass homeoboxes	HOXA2 HOXC5 HOXD13	1.07e-03	52	70	3	518
GeneFamily	Ribonuclease A family	RNASE1 RNASE6	1.12e-03	13	70	2	723
GeneFamily	CD molecules\|I-set domain containing\|Immunoglobulin like domain containing\|Interleukin receptors\|TIR domain containing	IL1RL1 IL1RAP	1.50e-03	15	70	2	1296
GeneFamily	Cyclophilin peptidylprolyl isomerases	PPWD1 PPIF	2.42e-03	19	70	2	909
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	MRC1 CEACAM6 ITGA3 IGF2R MME LY75	4.18e-03	394	70	6	471
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	MRC1 LY75	4.87e-03	27	70	2	1253
Coexpression	MADAN_DPPA4_TARGETS	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.24e-26	86	106	18	MM1312
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 PKP2 USP17L22 USP17L15 USP17L8 USP17L13	6.40e-26	112	106	19	MM1095
Coexpression	GERY_CEBP_TARGETS	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.16e-21	160	106	18	MM1155
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP20 PPIF USP17L18 USP17L17 TRIM32 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.42e-13	647	106	21	MM981
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	USP17L21 USP17L4 ISYNA1 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP20 PPIF USP17L18 USP38 USP17L17 TRIM32 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 PARP12 USP17L13	9.42e-11	1226	106	24	MM979
Coexpression	MARSON_BOUND_BY_FOXP3_STIMULATED	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 MAP3K1 USP17L18 USP8 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	9.91e-09	1072	106	20	MM1031
Coexpression	BRUINS_UVC_RESPONSE_LATE	CACNA1C USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 ENPP1 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.20e-08	1198	106	20	MM1062
Coexpression	BERGER_MBD2_TARGETS	REG1A REG1B RNASE1	1.04e-05	11	106	3	MM905
CoexpressionAtlas	dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_1000	ZBTB20 ENPP1 ABCC9 CSMD3 NRXN3 CNTN5	2.14e-06	91	88	6	gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k2_1000
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ADGRG3 CSMD3 ASAP1 IGF2R FCN1 KDM7A MME	2.92e-07	191	102	7	d4f77c73311d1149466bbfe4adbd6a301946ec90
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DSCAM LINGO2 CSMD3 LRP1B CNTN5 RBFOX1	8.23e-07	139	102	6	a1945b07f177cde40e7eea03a19236ce76165857
ToppCell	367C-Fibroblasts-Fibroblast-D-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MRC1 ADGRG3 MS4A4A RNASE1 RNASE6 FCN1	4.06e-06	183	102	6	b12b89debc9dd6396188bc8fe44f54c01c560966
ToppCell	367C-Fibroblasts-Fibroblast-D\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MRC1 ADGRG3 MS4A4A RNASE1 RNASE6 FCN1	4.06e-06	183	102	6	19cc0009f5332b6e4d4274df123eebbfc80b669a
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-myeloid\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MRC1 BCL3 MS4A4A RNASE1 FCN1 IL1RL1	4.89e-06	189	102	6	2aebea7a6c2f83112d7c504b742f2c04b92e459a
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1C LINGO2 CSMD3 NRXN3 RBFOX1 ADGRL2	6.02e-06	196	102	6	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	moderate-Myeloid\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ADGRG3 PPIF MS4A4A RNASE6 FCN1 MME	6.02e-06	196	102	6	76a4c615ea7594e99c1a938d6900a1b262cc09f5
ToppCell	NS-moderate-d_16-33-Myeloid\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ADGRG3 PPIF MS4A4A RNASE6 FCN1 MME	6.02e-06	196	102	6	dc8483625f1188771eb98bd94757b25163b2fc2f
ToppCell	3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 CASP1 MS4A4A RNASE1 RNASE6 FCN1	6.20e-06	197	102	6	fb69a7f4b6caf0a5c4dd69aaadd0c2685608feab
ToppCell	distal-Hematologic-IGSF21+_Dendritic-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MRC1 SPATA8 MS4A4A RNASE1 RNASE6 IL1RAP	6.38e-06	198	102	6	323b4e6c31e18227546bb30566c1d872fda45e36
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 CASP1 MS4A4A RNASE1 RNASE6 FCN1	6.38e-06	198	102	6	be038619157aeaa7a57ebd66392de940df4f8127
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1C LINGO2 CSMD3 NRXN3 RBFOX1 ADGRL2	6.38e-06	198	102	6	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DRD3 LINGO2 CSMD3 NRXN3 CNTN5 RBFOX1	6.76e-06	200	102	6	2f481e2fd248c02a5aa2e0248c16808df142fed2
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	DSCAM CSMD3 MAP3K1 RBFOX1 PLCB4 IL1RAP	6.76e-06	200	102	6	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	DSCAM CSMD3 MAP3K1 RBFOX1 PLCB4 IL1RAP	6.76e-06	200	102	6	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DRD3 LINGO2 CSMD3 NRXN3 CNTN5 RBFOX1	6.76e-06	200	102	6	bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	CACNA1C LINGO2 CSMD3 NRXN3 RBFOX1 ADGRL2	6.76e-06	200	102	6	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	DSCAM CSMD3 MAP3K1 RBFOX1 PLCB4 IL1RAP	6.76e-06	200	102	6	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DRD3 LINGO2 CSMD3 NRXN3 CNTN5 RBFOX1	6.76e-06	200	102	6	dc674124475edf83908b51a4e1454bc2dc4f06fa
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MRC1 ADGRG3 PPIF MS4A4A RNASE1 FCN1	6.76e-06	200	102	6	3c9e0dc62d14cc00023f7f18053c1a13085d3413
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	DSCAM CSMD3 MAP3K1 RBFOX1 PLCB4 IL1RAP	6.76e-06	200	102	6	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	DSCAM CSMD3 MAP3K1 RBFOX1 PLCB4 IL1RAP	6.76e-06	200	102	6	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	DSCAM CSMD3 MAP3K1 RBFOX1 PLCB4 IL1RAP	6.76e-06	200	102	6	961858738ce35db8760c8c2e136f8369bc444ccf
ToppCell	COVID-19-kidney-Technical/muscle_(EC)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DSCAM CSMD3 LRP1B CNTN5 RBFOX1	1.15e-05	128	102	5	91072ca56bce2c552a95edd67e17f43d8cc1de95
ToppCell	343B-Myeloid-Macrophage-SPP1+_Macrophage_4\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	USP49 MRC1 RNASE1 SHPK SLC5A8	1.49e-05	135	102	5	c4d3c9eba2a85ac40fea5ecfcc2b442a472323d0
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DSCAM CSMD3 LRP1B CNTN5 RBFOX1	2.32e-05	148	102	5	d6ac5972267254651dfbe16bb4e9a62228093cc7
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SLC26A9 ITGA3 USP44 PKP2 GAPDHS	2.32e-05	148	102	5	9fe3c0a5904b8e9a0f28130f8d84d4f2a819b06c
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSCAM SLC26A9 CNTN5 PKP2 PHLPP2	2.47e-05	150	102	5	47ea08d7609e1d2382bf56ef9e5c767e3597cf93
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DSCAM CSMD3 LRP1B CNTN5 RBFOX1	2.47e-05	150	102	5	0205318a870e091add66ee4305747dda9f51510d
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	DSCAM CSMD3 NRXN3 CNTN5 RBFOX1	3.27e-05	159	102	5	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	Club_cells-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	MXRA5 DSP WEE1 CEACAM6 LRP1B	3.47e-05	161	102	5	342f5c61d37df61b35c18f5d258043a8f5cef629
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA1C TECTA CSMD3 LRP1B USP26	3.58e-05	162	102	5	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	tumor_Lung-Myeloid_cells-Pleural_Mac\|tumor_Lung / Location, Cell class and cell subclass	MRC1 ENPP1 MS4A4A RNASE6 FCN1	3.58e-05	162	102	5	9ac3242511315224ed94582aca9e9a3786cd01a0
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	DSCAM CSMD3 NRXN3 CNTN5 RBFOX1	3.68e-05	163	102	5	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	COVID-19-Heart-T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DSCAM LINGO2 CSMD3 CNTN5 RBFOX1	4.63e-05	171	102	5	b2e753e811a7639956994609f73efcdb62d04f82
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DRD3 USP17L1 ABCC9 TECTA SLC5A8	4.76e-05	172	102	5	ddecdb1a0791296929790f78b49008f51a130f8b
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-Pleural_Mac\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	MRC1 PPIF RNASE6 FCN1 IL1RAP	4.89e-05	173	102	5	8384d533a1071fc65a06e6d9f5f17d8ab00c3966
ToppCell	10x5'-bone_marrow-Myeloid_Mac-Intermediate_macrophages\|bone_marrow / Manually curated celltypes from each tissue	ABCC9 MS4A4A RNASE1 FCN1 PKP2	5.02e-05	174	102	5	268abfc4d53a3ba3931dbcafffef09a72ea0edfa
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_macrophage\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MRC1 BCL3 MS4A4A RNASE1 FCN1	5.02e-05	174	102	5	7f1e26b58b66f4ac4c3bc315354bd620ad782eaa
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_macrophage-macrophage\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MRC1 BCL3 MS4A4A RNASE1 FCN1	5.02e-05	174	102	5	2479e4804253f55647d2192e40566d713419c51b
ToppCell	3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-Macrophages\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 CASP1 MS4A4A RNASE1 RNASE6	5.16e-05	175	102	5	fe27c3279f660b5be4193005394b77163c599d32
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGAP32 DSP WEE1 KDM7A SLC5A8	5.75e-05	179	102	5	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	Control-Myeloid-Monocytes,_Macrophages\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MRC1 CASP1 MS4A4A RNASE6 FCN1	5.75e-05	179	102	5	a79a244bf8ecc333d034b2eb2de554d3310ca6de
ToppCell	Control-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MRC1 CASP1 MS4A4A RNASE6 FCN1	5.75e-05	179	102	5	c4ff8b191ed0f6dc2dd784869f6f2c62e170a7db
ToppCell	LV\|World / Chamber and Cluster_Paper	ABCC9 RBFOX1 PKP2 PLCB4 ADGRL2	5.90e-05	180	102	5	5ac6f485a58bb29462fec02dfbe8eb70864eafe3
ToppCell	AT2_cells-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	CEACAM6 FASN RNASE1 WTIP SLC5A8	6.06e-05	181	102	5	ed0ea67f0607073aedf153f8d1073b35e46127c3
ToppCell	Control-Myeloid\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MRC1 CASP1 MS4A4A RNASE6 FCN1	6.06e-05	181	102	5	25170e5285996cc80337d5f86a0255569861ae77
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 CASP1 MS4A4A RNASE1 RNASE6	6.22e-05	182	102	5	de15a77b8d3527638bea5b04e0b2af03ac93bc18
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)\|343B / Donor, Lineage, Cell class and subclass (all cells)	DSCAM CEACAM6 ITGA3 RNASE1 WTIP	6.55e-05	184	102	5	cb15d6bae52c5ec251c2235859dc7e65f630ae23
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	DSCAM CEACAM6 ITGA3 RNASE1 WTIP	6.55e-05	184	102	5	bde4eaabd3e9bdaed23867d23a919b9d84b52d4b
ToppCell	wk_15-18-Mesenchymal-Mesothelial-Early_mesothelial\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ISYNA1 ITGA3 HOXC5 NRXN3 PKP2	6.89e-05	186	102	5	ae4b6ecfc1850c0a01a11b9dd9718880f2a24fe0
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CSMD3 LRP1B FCN1 CNTN5 KDM7A	6.89e-05	186	102	5	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CACNA1C LINGO2 LRP1B CNTN5 IL1RAP	6.89e-05	186	102	5	8915436d09775f2828a7678af203b1082b36e21c
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 CASP1 MS4A4A RNASE1 RNASE6	6.89e-05	186	102	5	c0a58e43a813441d3a1708236737b15db8bea10e
ToppCell	3'-Adult-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 MS4A4A RNASE1 RNASE6 FCN1	7.07e-05	187	102	5	8e1d6d25db5b5c91a651bb2d66edfcf073a31704
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	WEE1 LINGO2 ITGA3 LRP1B ADGRL2	7.07e-05	187	102	5	77886f99c229610abd28c4c370d2c7d1536c9782
ToppCell	control-Myeloid-Neutrophils_4\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ADGRG3 BCL3 IGF2R MME IL1RAP	7.25e-05	188	102	5	22d76c222fb0e3da08e10191af0090f14e03f2ad
ToppCell	IPF-Epithelial-ATII\|Epithelial / Disease state, Lineage and Cell class	SLC26A9 ABCC9 FASN RNASE1 SLC5A8	7.25e-05	188	102	5	5f5fad2773e421760e67dbace23fd1f847a2e1e0
ToppCell	PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MRC1 CASP1 MS4A4A RNASE1 RNASE6	7.43e-05	189	102	5	a438c64a893d43f781ede42e1c7b615b74dc76ef
ToppCell	IPF-Myeloid-cMonocyte\|Myeloid / Disease state, Lineage and Cell class	ADGRG3 BCL3 USP44 FCN1 IL1RAP	7.43e-05	189	102	5	ad7bb3a7de8e48c145e4382f90d30bb2159c2b76
ToppCell	Adult\|World / Lineage, Cell type, age group and donor	MRC1 CEACAM6 FASN NRXN3 SLC5A8	7.43e-05	189	102	5	5cd285bfad973125d46d704fec18b21266a63379
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRG3 WEE1 ITGA3 LRP1B RBFOX1	7.62e-05	190	102	5	bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e
ToppCell	control-Myeloid-CD14_Monocytes_2\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	TMEM144 MS4A4A RNASE1 RNASE6 FCN1	7.62e-05	190	102	5	47513757e0059e8370e49672a577f25ca842e98c
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MRC1 TMEM144 MS4A4A RNASE1 RNASE6	7.62e-05	190	102	5	081b7bc07b6e5685e8a91b9ae6c1141623723700
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRG3 WEE1 ITGA3 LRP1B RBFOX1	7.62e-05	190	102	5	b6b8964b4910083499681b5fdf554e127b6a4c4e
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BCL3 MS4A4A RNASE1 RNASE6 FCN1	7.62e-05	190	102	5	6cf9a41c1a0fa1ce6a8711caa7c71ff6b55df9e1
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MRC1 TMEM144 MS4A4A RNASE1 RNASE6	7.62e-05	190	102	5	912aa106581d1ed7e147c92f9a367e8e6b04052b
ToppCell	COVID-19-Heart-T_cell\|Heart / Disease (COVID-19 only), tissue and cell type	DSCAM LINGO2 CSMD3 LRP1B NRXN3	7.62e-05	190	102	5	e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf
ToppCell	TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood-Leukemia-Acute_Myeloid_Leukemia-2\|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9	USP17L5 HOXA2 SPATA31D4 USP44	7.64e-05	98	102	4	2407ffa8d3ccd108bb71095a75add672279a6a58
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 TMEM144 MS4A4A RNASE1 RNASE6	7.81e-05	191	102	5	51f5af610983aa73b9f4ece6f27d281ebff89a04
ToppCell	PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MRC1 TMEM144 MS4A4A RNASE1 RNASE6	7.81e-05	191	102	5	09dfad8e1fcaaf94775134796b99e4e3fbb9bf40
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 TMEM144 MS4A4A RNASE1 RNASE6	7.81e-05	191	102	5	8fd6bdc9d2b1c8d364221d7bc68d03921b668ab5
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MRC1 TMEM144 MS4A4A RNASE1 RNASE6	7.81e-05	191	102	5	bce138f067b8962ecef1ddec6511a3f142d81d78
ToppCell	PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte1_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MRC1 CASP1 MS4A4A RNASE6 FCN1	7.81e-05	191	102	5	367d300da3925e0a329271b5f19483a37265a878
ToppCell	NS-moderate-d_16-33-Myeloid-Neutrophil\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ADGRG3 BCL3 PPIF MME IL1RAP	8.00e-05	192	102	5	545c3990cbe3c04bfd95a0ab7499d2c4af509be1
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 MS4A4A RNASE1 RNASE6 FCN1	8.00e-05	192	102	5	22f335e6e75a694cdccafe189b5ee7815ef28c03
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CACNA1C MXRA5 ZBTB20 LRP1B CNTN5	8.00e-05	192	102	5	d0649410cf5eacdb0c1dce70e37c7473ef5fddfa
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Hematopoietic\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 CASP1 MS4A4A RNASE1 RNASE6	8.00e-05	192	102	5	453c11f468117ffdd8c248fee1e5bb1f5401cc33
ToppCell	moderate-Myeloid-Neutrophil\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ADGRG3 BCL3 PPIF MME IL1RAP	8.00e-05	192	102	5	8105408400dac5dcb0ce62b558433257559c9f09
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MRC1 TMEM144 MS4A4A RNASE1 RNASE6	8.00e-05	192	102	5	4e3deefd30adb7bf1eba294610eed3d077aa9418
ToppCell	PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MRC1 CASP1 MS4A4A RNASE6 FCN1	8.20e-05	193	102	5	9a6c5b7c8e88cf7a261f8e052df1709d2c0a91f0
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM3-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MRC1 MS4A4A RNASE1 RNASE6 FCN1	8.20e-05	193	102	5	93ba635ed69fec9286fe7636b9d258f3d93a22c3
ToppCell	PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MRC1 CASP1 MS4A4A RNASE1 RNASE6	8.20e-05	193	102	5	2684fa361baaa9dc7a18a39ed11c0759e78e4418
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM3\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MRC1 MS4A4A RNASE1 RNASE6 FCN1	8.20e-05	193	102	5	6dfdeb793cb5ad6412b6f808b5687a4e74b6ec65
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM3-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MRC1 MS4A4A RNASE1 RNASE6 FCN1	8.40e-05	194	102	5	e455cb469157c044126f9b0b308957d4ee1e608b
ToppCell	kidney_cells-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 MS4A4A RNASE1 RNASE6 IL1RAP	8.40e-05	194	102	5	abce1e824ce2512741c313a5ec336d12f580b093
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM3\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	MRC1 MS4A4A RNASE1 RNASE6 FCN1	8.40e-05	194	102	5	e0cfd18a7ea2251163d61312b9397f8a518c8c51
ToppCell	kidney_cells-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 MS4A4A RNASE1 RNASE6 IL1RAP	8.40e-05	194	102	5	6810586080cc893e3270b9c8bee2d95ed78e2893
ToppCell	(2)_Mono_macro\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	MRC1 MS4A4A RNASE1 RNASE6 FCN1	8.40e-05	194	102	5	7c05525614ee8cdfcbf22cce9146a8e73af7d14e
ToppCell	IPF-Myeloid-Macrophage\|World / Disease state, Lineage and Cell class	MRC1 ASAP1 MS4A4A RNASE1 RNASE6	8.61e-05	195	102	5	50edda117b438b9c3616191884007466f6d974f0
ToppCell	wk_20-22-Hematologic-Myeloid-S100A12-lo_cla._mono.\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	MRC1 CASP1 MS4A4A RNASE6 FCN1	8.61e-05	195	102	5	66273af9882f829b6fc0e20f03f3412294d37c26
ToppCell	3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 CASP1 MS4A4A RNASE1 RNASE6	8.61e-05	195	102	5	c14d730dd5c94247bc09711eaa5a53bd5a5957be
ToppCell	Non-neuronal-Postmitotic-Microglia-Microglia_low_quality-12\|World / Primary Cells by Cluster	TMEM144 CASP1 MS4A4A RNASE1 RNASE6	8.61e-05	195	102	5	d9d0f59ca0c86a5cfd1b9ecd8ad37d25f09f590e
ToppCell	Non-neuronal-Postmitotic-Microglia-Microglia_low_quality\|World / Primary Cells by Cluster	TMEM144 CASP1 MS4A4A RNASE1 RNASE6	8.61e-05	195	102	5	59b481ff24de3f95c34a1f8c74ff5ea6d7000a8e
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1C ARHGAP32 DSCAM CSMD3 RBFOX1	8.61e-05	195	102	5	2e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCell	Mild_COVID-19-Myeloid-MoAM3\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	MRC1 MS4A4A RNASE1 RNASE6 FCN1	8.82e-05	196	102	5	9faad17aa0b6af5a8ec2dadf7d70b9209d658072
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CASP1 RNASE1 RNASE6 FCN1 PKP2	8.82e-05	196	102	5	894f9943404cf252dbdf9e5769d9238f982ba8b8
ToppCell	ILEUM-non-inflamed-(3)_moDC\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MRC1 MS4A4A RNASE6 PKP2 IL1RAP	8.82e-05	196	102	5	e10f01172fd076d6892906853f9375d4c3058951
ToppCell	(3)_MNP\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	MRC1 PPIF MS4A4A RNASE6 FCN1	8.82e-05	196	102	5	c79403da5443710a6caf035a279e42bc324b27c9
ToppCell	3'-GW_trimst-1-LargeIntestine-Hematopoietic\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 MS4A4A RNASE1 RNASE6 FCN1	8.82e-05	196	102	5	5dbe38aef369811d981c0109829563ac66dcc684
Computational	Genes in the cancer module 96.	MRC1 REG1B FCN1 ADGRL2	5.39e-05	37	61	4	MODULE_96
Computational	Immune (humoral) and inflammatory response.	MRC1 ZBTB20 ENPP1 CASP1 MS4A4A RNASE1 RNASE6 FCN1 MME IL1RAP PARP12	2.17e-04	546	61	11	MODULE_84
Drug	hydroxyl radicals	ISYNA1 WEE1 HAGHL ENPP1 SLC26A9 REG1B USP37 LRP1B USP20 USP44 USP26 USP14 USP6 USP8 FASN RNASE1 USP38 PLCB4 MME GAPDHS USP33 PHLPP2	1.58e-08	1341	93	22	CID000000961
Drug	Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; PC3; HT_HG-U133A	MAGEA11 DSCAM ABCC9 TECTA HOXC5 RBFOX1 IL1RL1 ADGRL2	1.42e-06	196	93	8	5088_UP
Drug	AC1L1D90	ENPP1 USP14 GAPDHS CNTN2	8.59e-06	32	93	4	CID000002246
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.48e-35	46	106	19	DOID:5426 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.59e-31	69	106	19	DOID:1682 (implicated_via_orthology)
Disease	Brugada Syndrome (disorder)	CACNA1C ABCC9 PKP2	8.63e-05	24	106	3	C1142166
Disease	ribonuclease K6 measurement	RNASE1 RNASE6	1.27e-04	5	106	2	EFO_0802018
Disease	triacylglycerol 58:10 measurement	USP49 WTIP RBFOX1	2.49e-04	34	106	3	EFO_0010437
Disease	lithostathine-1-alpha measurement	REG1A REG1B	2.65e-04	7	106	2	EFO_0801083
Disease	Arrhythmogenic right ventricular cardiomyopathy	DSP PKP2	2.65e-04	7	106	2	cv:C0349788
Disease	obsolete_interleukin-1 alpha measurement	REG1A REG1B	2.65e-04	7	106	2	EFO_0802653
Disease	Sudden Cardiac Death	CACNA1C DSP	3.53e-04	8	106	2	C0085298
Disease	arrhythmogenic right ventricular cardiomyopathy (is_implicated_in)	DSP PKP2	5.65e-04	10	106	2	DOID:0050431 (is_implicated_in)
Disease	dimethylglycine measurement	CSMD3 CNTN5 ADGRL2	6.11e-04	46	106	3	EFO_0010476
Disease	Cardiomyopathy	DSP ABCC9 PKP2	6.51e-04	47	106	3	cv:C0878544
Disease	Shortened QT interval	CACNA1C ABCC9	6.88e-04	11	106	2	C0151879
Disease	Cardiomyopathy, Dilated	ABCC9 FASN PKP2	6.93e-04	48	106	3	C0007193
Disease	brain aneurysm	ARHGAP32 DSCAM LINGO2 RBFOX1	7.50e-04	113	106	4	EFO_0003870
Disease	nicotine dependence (implicated_via_orthology)	DRD3 PLCB4	8.24e-04	12	106	2	DOID:0050742 (implicated_via_orthology)
Disease	triacylglycerol 58:12 measurement	NRXN3 WTIP	8.24e-04	12	106	2	EFO_0010439
Disease	Hypertrophic Cardiomyopathy	CACNA1C DSP FASN	1.15e-03	57	106	3	C0007194
Disease	triacylglycerol 60:12 measurement	ZBTB20 WTIP	1.68e-03	17	106	2	EFO_0010444
Disease	Limb Deformities, Congenital	CACNA1C HOXD13	1.68e-03	17	106	2	C0206762
Disease	Alzheimer disease	MRC1 LINGO2 BCL3 MS4A4A NRXN3 RBFOX1 MME	1.87e-03	485	106	7	MONDO_0004975
Disease	autism spectrum disorder (implicated_via_orthology)	ARHGAP32 DSCAM NRXN3 PKP2	2.24e-03	152	106	4	DOID:0060041 (implicated_via_orthology)
Disease	adenosine diphosphate measurement	CNTN5 RBFOX1	2.33e-03	20	106	2	EFO_0010452
Disease	executive function measurement	CACNA1C LRP1B NRXN3 RBFOX1 SETD3 ADGRL2	2.41e-03	376	106	6	EFO_0009332
Disease	Autistic Disorder	CACNA1C DRD3 CSMD3 NRXN3 RBFOX1	2.56e-03	261	106	5	C0004352
Disease	advanced glycosylation end product-specific receptor ligand measurement	DSP OR14J1	2.57e-03	21	106	2	EFO_0010762
Disease	systemising measurement	DSCAM RBFOX1	2.57e-03	21	106	2	EFO_0010221
Disease	Nystagmus	REG1A REG1B	2.57e-03	21	106	2	HP_0000639
Disease	myocardial infarction (biomarker_via_orthology)	CASP1 REG1A REG1B ITGA3	2.69e-03	160	106	4	DOID:5844 (biomarker_via_orthology)
Disease	interleukin 10 measurement	DSCAM FCN1 ADGRL2	2.82e-03	78	106	3	EFO_0004750
Disease	monocyte measurement	RNASE1 RNASE6 FCN1	3.25e-03	82	106	3	EFO_0803547

Protein segments in the cluster

Peptide	Gene	Start	Entry
GNTCYMNAVLQSLLS	USP26	301	Q9BXU7
ALCGGNITAMNGTIY	CSMD3	2281	Q7Z407
TCLGSNNMYDIFNLN	ADGRG3	31	Q86Y34
GHQLQMCYQISRGNS	ADGRL2	1416	O95490
FLQSNQESFMNGICG	CALHM1	11	Q8IU99
MSLSFCGNNISSYNI	ABCC9	1	O60706
CNLAMTQNYEGQLQS	DEUP1	81	Q05D60
HNVNQSDAGMYQCLA	CNTN5	446	O94779
CGSCLEGSAQQMYQS	HAGHL	141	Q6PII5
YNQSEAGSHTLQGMN	HLA-F	106	P30511
TMSIVSYNHLGNNDG	ISYNA1	326	Q9NPH2
MQTCGNYGSASEVQA	HOXC5	21	Q00444
GKYMQNSNLTSGACQ	KDM7A	856	Q6ZMT4
YMDGQNCRNSLGSVD	LRP1B	4566	Q9NZR2
NLSYDGIQCNEQSMP	MAGEA11	296	P43364
LNDTGNYTCMLRNTT	IL1RAP	106	Q9NPH3
VNNSGSYMCQAHNSA	CEACAM6	291	P40199
SYMCQAHNSATGLNR	CEACAM6	296	P40199
NSNTDYLETGMCQLG	ITGA3	186	P26006
ANSLMGNGYISLVQC	OR14J1	81	Q9UGF5
SAQQSNSLNYGGIGM	MME	566	P08473
SMTSYSGNQCNDPGA	NRXN3	1076	Q9Y4C0
YEALNMCSQSGGHLA	LY75	1416	O60449
QDSGMYVCIASNAAG	LINGO2	476	Q7L985
ICLLSQHQFMSGYSQ	ENPP1	671	P22413
SASFNGEMLGNRCNS	ARHGAP32	736	A7KAX9
SHCLNFNAMTYGATQ	PARP12	341	Q9H0J9
LGYNFSSEAGMNAIC	NPC1L1	906	Q9UHC9
ADCHASNLNGLYLMG	FCN1	281	O00602
SLMQAADANGLQNGY	ASPHD2	91	Q6ICH7
GQNQSFSNGLACLDM	IL1RL1	271	Q01638
GNYLNMQDSQGVLSS	CASP1	96	P29466
LNTICLAMQHYGQSC	CACNA1C	1251	Q13936
SNIQMDSGYNTQNCG	BORA	491	Q6PGQ7
DSGYNTQNCGSNIMD	BORA	496	Q6PGQ7
QNSDGYCQTGTMSRH	DSP	51	P15924
YSCRMSHGVGLQQNA	HOXD13	136	P35453
GSQLCQAHSQLLQYM	DDX12P	431	Q92771
QSRQGGYSMHQLQGN	ASAP1	306	Q9ULH1
NAQLRHGGKYTCMAQ	CNTN2	576	Q02246
NYYGNSNNCHGTMSI	MS4A4A	166	Q96JQ5
YGGQMTTSASNQTLC	KLF18	276	A0A0U1RQI7
YGGQMTTSASNQTLC	KLF18	626	A0A0U1RQI7
MALQNAYQAIHSGQC	FASN	166	P49327
YNPGSMNIVSNASCT	GAPDHS	211	O14556
LQHGANVNAQMYSGS	BCL3	296	P20749
YQISMCELGSANGVT	SEC22A	151	Q96IW7
MASLSQLSGHLNYTC	DRD3	1	P35462
DLYCQNMNSGNLVSV	REG1A	61	P05451
DLYCQNMNSGNLVSV	REG1B	61	P48304
NCLSTMGQNCGAGLN	HOXA2	296	O43364
MYTLLGNANGATCAF	MRC1	156	P22897
SCYQAQDVGTGTLMA	MAP3K1	1256	Q13233
ISNLSLMHNGNYTCI	DSCAM	656	O60469
SLSIMYVNGDKCGNQ	IGF2R	1166	P11717
CQANQEGSSMYSAPS	RBFOX1	231	Q9NWB1
SCGNMSVQALQSLPY	RHNO1	136	Q9BSD3
MNCQGLIGVTDSYDN	TRIM32	436	Q13049
NAGCQMVSLNYQTPD	PLCB4	641	Q15147
NQEMIALGCSNFFGS	SLC26A9	366	Q7LBE3
SGMNLQICFVNDSGS	SCHIP1	296	P0DPB3
YTLSMANAGSNTNGS	PPWD1	576	Q96BP3
MCNHTNGLITTGYNL	SETD3	276	Q86TU7
ALGDLQASVYSCMAQ	SHPK	256	Q9UHJ6
DIQGCNSTYNETNLM	SLC5A8	476	Q8N695
LSMENVGNYQGCSQE	SPATA31D4	761	Q6ZUB0
CNRAMSGINNYTQHC	RNASE6	46	Q93091
SFMCQAGDFTNHNGT	PPIF	101	P30405
GQGNCYKSNSSMHIT	RNASE1	96	P07998
NCGNIVQSNGTHIMY	TECTA	1856	O75443
GLQNMGNTCYENASL	USP17L3	81	A6NCW0
LSMENVGNYQGCSQE	SPATA31D3	761	P0C874
HMLIQNEYCNGGSLA	WEE1	371	P30291
GLQNMGNTCYENASL	USP17L4	81	A6NCW7
LAQSYGCQDNVGAMV	PHLPP2	1016	Q6ZVD8
FMENGSLSGLLQSQC	RIPK3	96	Q9Y572
MSNNGADLTFGYISC	TMEM144	1	Q7Z5S9
MSGAQDNSCLYQEIA	SPATA8	6	Q6RVD6
GLQNMGNTCYVNASL	USP17L18	81	D6R9N7
GVTGLRNLGNTCYMN	USP49	251	Q70CQ1
GLQNMGNTCYVNASL	USP17L5	81	A8MUK1
GLQNMGNTCYVNASL	USP17L21	81	D6R901
GLQNMGNTCYVNASL	USP17L13	81	C9JLJ4
GLQNMGNTCYVNASL	USP17L19	81	D6RCP7
SHSYGNCLGMTLQSQ	RFX7	806	Q2KHR2
GLQNMGNTCYENASL	USP17L1	81	Q7RTZ2
GLINLGNTCYMNSVI	USP38	446	Q8NB14
GNSCYMNAALQALSN	USP20	151	Q9Y2K6
ALYACSMQNGSGERS	ZBTB20	246	Q9HC78
GLQNMGNTCYVNASL	USP17L12	81	C9JPN9
QGFSNLGNTCYMNAI	USP37	341	Q86T82
GLQNMGNTCYVNASL	USP17L24	81	Q0WX57
GLQNMGNTCYLNASL	USP17L8	81	P0C7I0
GIYGAQQACQAMGSL	WTIP	231	A6NIX2
GLQNMGNTCYVNASL	USP17L6P	81	Q6QN14
SQMDRQGQGSHYGQT	RPTN	416	Q6XPR3
GLQNMGNTCYVNASL	USP17L22	81	D6RA61
GLTNLGNTCYMNATV	USP14	106	P54578
GLQNMGNTCYVNASL	USP17L15	81	C9J2P7
GLQNMGNTCYVNASL	USP17L17	81	D6RBQ6
YNVTGCLRNMSSAGA	PKP2	556	Q99959
LTGLRNLGNTCYMNS	USP8	776	P40818
GVTGLRNLGNTCYMN	USP44	271	Q9H0E7
ATGLSNLGNTCFMNS	USP6	531	P35125
GLQNMGNTCYVNASL	USP17L23	81	D6RBM5
GLQNMGNTCYENASL	USP17L2	81	Q6R6M4
GLKNIGNTCYMNAAL	USP33	186	Q8TEY7
GNTCYMNAALQALSN	USP33	191	Q8TEY7
GLQNMGNTCYVNASL	USP17L20	81	D6RJB6
GLQNMGNTCYVNASL	USP17L10	81	C9JJH3
GLQNMGNTCYVNASL	USP17L11	81	C9JVI0
ELVGNSSYQNSSGLM	VPS13D	2541	Q5THJ4
GIYSCMAQNTAGGLS	LRIG2	671	O94898
QDRGQYMCTASNLHG	MXRA5	1921	Q9NR99